Nov 8, 2023 10:37:27 AM
Do you want to reduce costs in your viral vector manufacturing process? Bring in DENARASE®!
Endonucleases are widely used in the manufacturing of viral vectors for cell and gene therapies....
read more
Sep 13, 2023 11:02:12 AM
c-LEcta increases market presence in the USA
c-LEcta establishes a US warehouse for R&D-grade DENARASE® portfolio and partners with local...
read more
Jun 26, 2023 12:00:00 AM
c-LEcta @ Bioprocessing Summit & BPI Boston
In August and September c-LEcta is presenting their DENARASE® portfolio: DENARASE® for research and...
read more
May 4, 2023 10:31:00 AM
Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from c-LEcta
During BPI US West in San Diego, our Head of Marketing Raphael Gübeli talked about recent trends...
read more
Apr 19, 2023 11:33:00 AM
US FDA DMF Support for DENARASE® GMP-grade
c-LEcta successfully filed a Drug Master File (Type II) with the US FDA in 2021. We spoke with Dr....
read more
Mar 28, 2023 11:05:00 AM
Kerry and c-LEcta enter agreement to market DENARASE® products
Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in...
read more
Feb 14, 2023 10:54:00 AM
BioProcess International US West, San Diego
From February 27 - March 2, 2023 the BPI US West will take place in San Diego. The BPI US West...
read more
Feb 1, 2023 10:59:00 AM
New sizes of R&D-grade DENARASE® available
c-LEcta has just launched additional sizes of DENARASE®for research and development use. Being...
read more
Aug 31, 2021 11:10:00 AM
Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA
c-LEcta has announced the submission of a Master File for its best-selling product DENARASE®. The...
read more